Questions, answered.

Click any Book Free T-Check button on the site, call (817) 749-6946, or text us. We typically have same-week appointments available, and the first visit is genuinely free—no card on file required to book.

About fifteen minutes, start to finish. We do an on-site testosterone check (same-day result), a body composition scan, and you sit down with a board-certified physician to talk through your goals and history. You leave with a clear sense of whether testosterone, GLP-1, peptides, or none of the above is right for you.

Yes. The first visit is completely free—the testosterone check, the body comp scan, and the physician consultation are all included at no cost. There's no charge, no hidden fee, and no commitment to start treatment afterward. We do this because it's the fastest way for both of us to know if we're a fit.

Bring any recent labs (within the last 12 months, especially testosterone or thyroid panels), a list of current medications and supplements, your insurance card if you have one, and an HSA/FSA card if you plan to use it. If you don't have any of that, come anyway—we can run everything on-site.

No fasting required for the first visit. The testosterone check we do on-site doesn't need a fasting state. If we end up running a full metabolic panel on a follow-up, we'll ask you to fast 8–10 hours before that appointment specifically.

Total testosterone peaks in the morning, usually between 7 and 10 a.m. We schedule first visits and follow-up labs in that window when possible. If your schedule doesn't allow morning visits, that's fine—we adjust our interpretation of the result and can confirm with a repeat test if anything looks borderline.

Most patients who qualify for treatment can start within 3–7 days. After your free visit, we run any additional labs needed, your protocol is built or reviewed by Dr. Abdullah, and the medication ships from our compounding pharmacy. You're typically injecting (or starting GLP-1) within a week.

Absolutely encouraged, especially for ED, fertility, or hormone conversations. Many of our patients bring a partner to the first visit—it helps with treatment decisions and downstream communication. Just let us know in advance so we have an extra chair.

Our all-inclusive cash program is $199/month. That covers your testosterone medication, weekly in-clinic injections, full lab panels (total T, free T, estradiol, hematocrit, SHBG, metabolic markers), body composition scans, and physician follow-ups. There are no add-on fees and the price never increases.

Yes. We accept most major plans including Blue Cross Blue Shield, Aetna, UnitedHealthcare, Cigna, Humana, and Medicare. Insurance can cover the office visit and diagnostic labs when clinical criteria are met. Medications are sourced through our licensed compounding pharmacy and are not billed to insurance. We verify your benefits before your visit.

Yes. Our entire $199/month cash program is HSA- and FSA-eligible because it's a qualified medical expense under a physician treatment plan. Most patients pay with pre-tax dollars, which effectively brings the monthly cost into the $130–$160 range depending on your tax bracket.

Most plans require two morning testosterone readings under the threshold (often <300 ng/dL) plus documented symptoms. Plans also vary on coverage for compounded testosterone vs. brand-name (e.g., Testim, AndroGel). Some require a prior authorization or step therapy. We handle the paperwork; if your plan denies coverage, we walk you through the cash option without pressure.

We have a free coverage checker that gives you a probability estimate before you book. We also verify your specific benefits during your free visit—so you know exactly what your insurance will and won't cover before you commit to anything.

Everything related to your testosterone treatment: the medication itself (testosterone cypionate or topical), weekly in-clinic injections, full lab panels every 6–12 weeks, body composition scans, physician visits, and adjustments to your protocol. The only thing not included is medication for other treatments (GLP-1, peptides, etc.), which are priced separately.

GLP-1 starts at $199/month for compounded semaglutide and $349/month for compounded tirzepatide. Brand-name Wegovy or Zepbound through insurance varies widely depending on your plan and prior authorization. Our cash program includes the medication, dose escalation, weekly check-ins, and labs.

No. Our pricing is flat. The first visit is free. The cash program is the price advertised. Lab fees, follow-up visits, and minor adjustments are all included. The only optional add-ons are services like NAD+ IV ($150–$300/session) or P-Shot ($1,700) that you choose separately. Everything is itemized clearly on your invoice.

Yes. There's no annual contract. Email or call to cancel and you stop being billed the next cycle—no cancellation fee, no penalty. We'll provide your medical records to your next provider on request, free of charge.

Yes. The most common combo is TRT + GLP-1 at $349/month all-inclusive—a savings vs. paying for each separately. Peptide therapy is $49/month membership on top of either program. We can build a custom bundle if you're using multiple treatments.

Most men notice changes in energy, sleep quality, and morning function within 2–4 weeks. Body composition (muscle, fat distribution) and strength take 8–12 weeks. Full benefits typically emerge by month four, after the first dose calibration. If you don't feel changes by week six, that's a signal to adjust the protocol—not to wait longer.

When properly monitored, yes. The known risks—elevated hematocrit (red blood cell concentration), estrogen elevation, and prostate-related changes—are well-understood and managed through routine bloodwork. Our protocol checks the relevant markers every 6 weeks at first, then quarterly. The greater risk for most men is leaving suboptimal levels untreated for years.

Yes. Exogenous testosterone suppresses natural production and reduces sperm count, sometimes to zero. If you're planning to have children in the next 1–3 years, we discuss alternatives like enclomiphene or hCG-paired protocols before starting. Tell us at your first visit—fertility can be preserved with the right approach, but it's much easier to plan upfront than retrofit later.

Injections (testosterone cypionate, weekly) produce the most stable serum levels with the simplest dosing and lowest cost; they're our default. Topicals (cream/gel, daily) are useful when injections aren't preferred. Pellets (every 3–6 months) are convenient but the dose can't be adjusted once placed. We discuss all three at your visit and choose based on your schedule, response, and labs.

We use weekly testosterone cypionate injections in-clinic by default. Some patients split into twice-weekly self-injection at home for steadier serum levels. The right cadence depends on your trough/peak ratio on labs and how you feel between doses—we adjust based on data, not a fixed protocol.

Most insurance and most evidence-based protocols use a threshold of two morning total testosterone readings below 300 ng/dL plus documented symptoms (low energy, low libido, depressed mood, poor recovery). Some men feel terrible at 350–450 ng/dL with low free testosterone or high SHBG—those cases we evaluate individually. We don't prescribe TRT to men with normal labs and no symptoms.

The standard "normal" range (often 250–950 ng/dL) is wide and doesn't account for free testosterone, SHBG, or symptoms. Many men feel terrible at 350 ng/dL who feel themselves at 700. We treat people, not lab numbers—but we also rule out other causes (thyroid, sleep apnea, depression, vitamin deficiencies, medications) before defaulting to TRT. The free visit sorts that out.

Most patients don't. Aromatase inhibitors (like anastrozole) are over-prescribed in many TRT clinics. We only add one if your estradiol climbs into a range that's actually causing symptoms (sensitive nipples, water retention, mood changes) or labs trend in a way that warrants intervention. Crashing estrogen causes more problems than it solves.

Absolutely. Many of our patients switched from other clinics. We make the transition easy—bring your most recent labs and current dosing, book a free testosterone check, and we'll review your current protocol against your goals. No need to interrupt treatment during the transition.

Yes, but the body takes 6–12 weeks to resume natural production after stopping. During that window, you'll likely feel worse than baseline as your HPG axis restarts. If discontinuation is the goal, we run a structured taper with hCG to support endogenous production—not a cold stop.

No, when properly dosed. The "roid rage" stereotype comes from supraphysiologic doses used in bodybuilding (5–10x therapeutic). Therapeutic TRT brings men back to normal physiologic levels and most patients report improved mood stability, not worse. If you feel mood swings on treatment, your dose is likely off—we adjust.

It can accelerate male-pattern baldness in men genetically predisposed (the issue is DHT conversion, not testosterone itself). If you're already noticing thinning, we discuss adjuncts—finasteride, topical minoxidil, or microneedling/PRP for the scalp. TRT alone doesn't cause hair loss in men who weren't going to lose it anyway.

Tirzepatide (Zepbound, Mounjaro) is a dual agonist hitting both GLP-1 and GIP receptors and tends to produce greater weight loss with similar tolerability. Semaglutide (Ozempic, Wegovy) targets GLP-1 only and has a longer track record. We start most patients on whichever fits their goals and budget; tirzepatide is the more powerful option, semaglutide the more economical.

Realistic average for tirzepatide is 15–22% body weight over 12 months; for semaglutide, 10–15%. Individual response varies widely depending on dose tolerated, baseline weight, dietary changes, and resistance training. The biggest predictor of long-term success is whether you build infrastructure (protein intake, strength training, sleep) during the medication phase.

Appetite reduction typically kicks in within the first week. Visible weight loss starts at week 3–4. The most rapid loss happens between weeks 8–20 as you escalate dose. By month 6, most patients are 60–70% of their total weight-loss curve. The last 10–20% takes another 4–6 months.

Nausea, constipation, fatigue, occasional reflux—mostly during dose-escalation weeks. Severe side effects (gallbladder issues, pancreatitis, severe vomiting) are uncommon and we screen for risk factors upfront. Most side effects fade as your body adapts. We slow the titration if you're struggling—there's no medal for ramping faster than you can tolerate.

Most patients regain a portion if they stop without infrastructure in place. Studies show ~⅔ of weight-loss returns within 12 months of stopping the medication if nothing else has changed. The protocol pairs the medication with strength training, protein-prioritized eating, and sleep optimization specifically to make the loss durable past the medication.

Yes—they're complementary. TRT builds and preserves lean muscle while GLP-1 drives fat loss. Used together, body composition outcomes are significantly better than either alone (less muscle loss, more fat loss, better metabolic markers). We bundle this combo at $349/month.

You don't have to, but you should. Without resistance training, ~25% of the weight you lose on GLP-1 will be muscle. Three short strength sessions per week (45 minutes each) preserves nearly all of that muscle and keeps your metabolism intact. We give patients a simple 3-day program at no extra cost.

Slow titration is the biggest lever—we don't move you up a dose level until the previous one is well-tolerated. Eating smaller, lower-fat meals helps. Anti-nausea agents (ondansetron, ginger) are available short-term if needed. Severe or persistent nausea is a signal we're going too fast, not that you need to push through.

Plateaus are normal and usually reflect either dose ceiling (you've titrated as high as you'll go) or behavioral drift (calorie creep, less protein, less training). We re-baseline labs, look at sleep and stress, audit nutrition, and decide whether to switch medications, add a complementary tool (metformin, low-dose naltrexone), or accept the new set point.

Compounded semaglutide and tirzepatide are made by licensed 503A compounding pharmacies and have been used safely by hundreds of thousands of patients during the FDA shortage period. We source from US-licensed pharmacies with rigorous quality testing. Compounded versions are functionally identical to brand-name; the molecule is the molecule.

Retatrutide is Eli Lilly's investigational triple agonist—it activates GLP-1, GIP, and glucagon receptors. The glucagon arm is the new piece: it increases resting energy expenditure (your body burns more calories at baseline), which appears to be why it produces deeper weight loss than tirzepatide. It is currently in late-stage Phase 3 trials and is not yet FDA-approved.

Eli Lilly's TRIUMPH-3 topline results (2026) reported more than 29% body weight loss at the highest dose over the trial period—the largest weight-loss effect ever reported for a GLP-1-class medication. For comparison: tirzepatide produces ~22%, semaglutide ~15%. Real-world results in the post-approval setting will refine this number, but the trial data is compelling.

Eli Lilly is reading out its remaining Phase 3 trials through 2026, with an FDA filing (NDA) projected for late 2026 or early 2027. Approval and US launch most likely fall in the 2027–2028 window. We're tracking the trial readouts and the FDA timeline closely and will update this answer as the dates firm up.

Probably not. Retatrutide is still at least 18–24 months out, and every additional month at higher body weight is another month of metabolic dysfunction, suppressed testosterone, and elevated cardiovascular risk. The more pragmatic move is to start now with a proven option (tirzepatide or semaglutide) and transition if and when retatrutide becomes available. Most of the weight you'd lose on retatrutide can also be lost on tirzepatide—the gap is meaningful but not the difference between success and failure.

Phase 3 data so far suggests retatrutide's tolerability profile is broadly similar to tirzepatide—same GI side-effect class (nausea, constipation, occasional vomiting) at similar rates, with slow titration as the primary management lever. The glucagon-receptor activity raises additional watch-points around resting heart rate and liver function that will need close monitoring. We'll have a full safety picture once Lilly publishes the complete TRIUMPH dataset.

Four main drivers: vascular (blood flow), neurogenic (nerve signaling), hormonal (testosterone, prolactin, thyroid), and psychogenic (stress, anxiety, depression). Most cases are mixed. The first step is figuring out which apply to you, then mapping treatment to cause—not just throwing PDE5 inhibitors at the symptom.

PDE5 inhibitors (Viagra, Cialis) work in roughly 70–80% of men with mild-to-moderate vasculogenic ED. They won't fix hormonal, neurogenic, or psychogenic causes alone. We use them as first-line, but if you're not responding well or don't want to rely on them daily, we have other options.

Daily low-dose tadalafil (2.5–5 mg) gives steady-state coverage and is preferred by men who want spontaneity. As-needed dosing (10–20 mg, 30 minutes before activity) is fine for less frequent use. Daily dosing also has small side benefits for prostate symptoms in older men. We pick based on your usage pattern.

Shockwave (sometimes called softwave) uses focused acoustic energy to stimulate microvessel growth in penile tissue. Evidence supports meaningful improvement in mild-to-moderate vasculogenic ED. It's a 6-session series. Works best as an adjunct to PDE5 medication, not always a replacement, but for some men it reduces or eliminates the need for daily pills.

The P-Shot is platelet-rich plasma (PRP) injected into the penile tissue to stimulate vascular and tissue regeneration. It's a single in-office procedure under local anesthetic. Best evidence supports its use for mild-to-moderate ED and Peyronie's disease. Results develop over 3–6 months; many patients combine it with shockwave for compounding effects.

Yes—about 20–30% of ED cases have a hormonal component. Low T affects libido (desire) more than mechanical function, but in men with significantly low levels, both are impaired. Treating the underlying low T often improves ED with or without PDE5 medication. We check T at every ED workup.

Often, yes. Vascular ED responds to lifestyle changes, hormone optimization, PDE5 inhibitors, shockwave, or PRP. Hormonal ED reverses with proper hormone treatment. Psychogenic ED resolves with addressing the underlying stress or anxiety. Truly irreversible ED (severe nerve damage from prostatectomy, advanced diabetes complications) is the minority of cases.

ED is a vascular health signal. New-onset ED in a man under 60 raises questions about cardiovascular risk—endothelial dysfunction in penile arteries often shows up before coronary symptoms. We work up cardiovascular risk factors (lipids, blood pressure, glucose) at the same time we treat the ED, because they're often connected.

Yes, when it's the primary driver. We don't do talk therapy in-clinic, but we coordinate with men's health-trained therapists, recommend evidence-based protocols (sensate focus, ACT-based work), and use short-acting PDE5 inhibitors strategically to break the anxiety loop. Most performance anxiety resolves once a few good experiences reset expectations.

When we work through the four drivers properly, about 85–90% of men report meaningful improvement. That doesn't mean every man becomes 22 again, but it does mean most regain reliable function. The 10–15% who don't respond fully are usually men with severe vascular disease or post-surgical nerve damage—still treatable, just with a different toolkit (penile injections, vacuum erection devices, implants in rare cases).

In men's health: growth hormone axis support (sermorelin, ipamorelin, CJC-1295), recovery and tissue repair (BPC-157, TB-500), sexual health (PT-141), and weight loss adjuncts. Peptides are short chains of amino acids that signal specific receptors—more targeted than systemic hormones, with different risk/benefit profiles depending on the specific peptide.

The landscape is evolving. Sermorelin, tesamorelin, and PT-141 (Vyleesi) are clearly compoundable or FDA-approved. BPC-157 and TB-500 were removed from the FDA's Category 2 list in April 2026 and are pending a Category 1 vote in July 2026. Ipamorelin and CJC-1295 were reviewed by the FDA's advisory committee in late 2024. Read our peptide guide for the current map.

Most are subcutaneous self-injection with a tiny insulin-style needle—pinch a fold of skin near the navel, inject, done in 10 seconds. A handful (BPC-157 oral, PT-141 nasal, GHK-Cu topical) have non-injectable forms. We teach injection technique at your first peptide visit and provide all supplies.

Depends on the peptide. BPC-157 for an injury: 1–2 weeks. Growth-hormone-releasing peptides (sermorelin, ipamorelin) for sleep and recovery: 3–4 weeks. Body composition changes: 8–12 weeks. PT-141 for sexual function: same-day, hours after dosing. We set realistic expectations upfront.

Yes, and most of our patients do. Peptides target different pathways than testosterone, so they stack cleanly without interaction. The most common combo is TRT + sermorelin/ipamorelin for sleep, recovery, and body composition. BPC-157 + TRT during a heavy training phase is another common pairing.

When sourced from licensed compounding pharmacies and dosed properly, the safety profile is favorable. Side effects are typically mild (injection-site irritation, occasional flushing or fatigue). We avoid peptides with unclear safety data or off-list status, screen for contraindications (active cancer, pregnancy planning), and monitor labs during therapy.

We charge a $49/month membership that covers physician oversight, prescription management, dose adjustments, and follow-up labs. The peptides themselves are billed separately based on what you're prescribed—typical range is $80–$250 per month depending on the peptide and dose.

We work exclusively with US-licensed 503A compounding pharmacies that follow USP <797> standards and provide third-party purity testing. We won't prescribe from research-chemical suppliers or international sources. The pharmacy ships directly to you, refrigerated where required.

Platelet-rich plasma drawn from your own arm, processed to concentrate growth factors, then injected into the corpus cavernosum and glans under local anesthetic. The growth factors stimulate angiogenesis (new microvessels) and tissue regeneration over the following weeks. Single in-office procedure, 45 minutes.

Local anesthetic is applied first, plus a numbing cream. Most patients describe the actual injection as pressure rather than pain. Mild soreness for 24–48 hours afterward is normal. You can have intercourse the same evening if you want, though many wait 24 hours.

Most patients see effects beginning at 3 weeks, peak at 3 months, and durable through 12–18 months. Some men do annual maintenance shots; others do a single shot and don't need another. Combining with shockwave during the same window tends to extend results.

A series of low-intensity acoustic pulses delivered to penile tissue with a handheld applicator—non-invasive, no injections. Stimulates microvessel growth and breaks up small areas of fibrosis. Typical course is 6 sessions over 3 weeks, no downtime. Works best for vasculogenic ED.

Shockwave is non-invasive acoustic energy stimulating the existing vascular network. P-Shot is an injection of regenerative growth factors. They work through different mechanisms and stack well—many of our patients do a shockwave series followed by a P-Shot, or run both during the same 8-week window.

Men with mild-to-moderate vasculogenic ED, Peyronie's disease (curvature/plaques), reduced sensation post-prostatectomy, or men who want optimization beyond medication. Less ideal: severe ED from advanced diabetes or radiation damage, men on blood thinners (relative contraindication), active genital infection. We screen at the consult.

P-Shot is $1,700 single procedure (includes labs, PRP processing, the procedure itself, and a 30-day follow-up). Shockwave package is typically $2,400 for 6 sessions. Combo packages are available. None of this is covered by insurance—it's elective regenerative medicine.

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme involved in mitochondrial energy production and DNA repair. Levels decline with age. IV NAD+ delivers a high-dose bolus that supports cellular energy, mental clarity, and recovery. The strongest evidence is for mitochondrial dysfunction, post-viral fatigue, addiction recovery support, and pre-event energy/recovery.

Honest answer: probably not in the way TikTok claims. NAD+ supplementation supports specific cellular functions, but "reverses aging" is overstated marketing. We position NAD+ as a recovery and energy tool, not a longevity miracle. If you've seen the science, you know the picture is more nuanced than the influencer pitch.

Push (rapid IV injection over 5–15 minutes) delivers a higher concentration faster but is more intense and can cause flushing or chest tightness. Drip (slow infusion over 1–2 hours) is gentler with similar end-state benefits. We default to drip for first-time patients; push works well for veterans who tolerate it.

Loading phase: 5–10 sessions over 2–3 weeks if you have specific symptoms (post-viral fatigue, brain fog, energy crash). Maintenance: 1 session per month to every 3 months. We don't recommend weekly indefinitely—diminishing returns and unnecessary cost.

Myers' cocktail (B-vitamins, magnesium, calcium, vitamin C) for general recovery; high-dose vitamin C (10–25g) for immune support; glutathione (antioxidant); recovery blends post-event. We don't offer hangover IVs as a marketing gimmick—if you're chronically dehydrated from drinking, the issue isn't a $200 IV.

Standard IVs (Myers', recovery blend, glutathione) are $150–$250. NAD+ pricing depends on dose: $300 for 250mg, $450 for 500mg, $700 for 1000mg. Frequent users can buy a 6-pack at a discount. Add-ons (B12, B-complex, extra glutathione) are $20–$40 each.

Platelet-rich plasma. We draw your own blood, spin it in a centrifuge to concentrate the platelets and growth factors, then inject the concentrated plasma into the target tissue—a joint, the scalp, the penis, or a tendon. The growth factors stimulate the body's repair mechanisms more aggressively than baseline healing.

Knee, shoulder, hip, and elbow osteoarthritis or tendinopathy; rotator cuff partial tears; tennis/golfer's elbow; hair loss (androgenetic alopecia); ED and Peyronie's (the P-Shot); post-surgical recovery support. We don't offer PRP for everything—if the evidence isn't there, we say so.

Evidence is strongest for knee osteoarthritis (multiple RCTs showing 6–12 month improvement), tennis elbow (chronic cases), androgenetic alopecia (modest but real), and ED (the P-Shot). Evidence is mixed or weak for many other indications—we'll tell you which category your case falls into before you commit to a series.

Joints typically respond to 1–3 sessions spaced 4–6 weeks apart, with results lasting 9–18 months. Hair restoration is usually a 4-session series at monthly intervals followed by maintenance every 4–6 months. P-Shot is often a single shot, repeated annually if maintenance is desired.

Mild soreness or stiffness for 24–72 hours at the injection site is normal. Avoid NSAIDs (ibuprofen, naproxen) for 7 days before and 14 days after—they blunt the inflammatory healing response that makes PRP work. Acetaminophen is fine. Most patients return to normal activity within 48 hours.

Single-joint PRP: $900–$1,200 per session. Hair restoration: $700–$900 per session. P-Shot: $1,700 single procedure. Multi-session packages save ~15% vs. paying per session. Not covered by insurance.

Full panel: total testosterone, free testosterone, SHBG, estradiol (sensitive assay), LH, FSH, prolactin, PSA (men 40+), CBC (for hematocrit), CMP (kidney/liver), lipid panel, fasting insulin, A1c, thyroid panel, vitamin D, ferritin. We also run baseline DHEA-S and cortisol when symptoms warrant. This is a more complete panel than most TRT clinics run, and it's all included in the cash program.

Baseline at intake. Recheck at 6 weeks after starting TRT to confirm the protocol is dialed in. Then quarterly for the first year, semi-annually after that if levels are stable. GLP-1 patients get labs every 12 weeks during dose escalation. Peptide patients get labs every 12–16 weeks.

Yes, all labs related to your treatment are included in the $199/month cash program (TRT) or $349 combo (TRT + GLP-1). If you want labs outside our scope (specialty hormone panels, food sensitivity testing, comprehensive cardiovascular risk panels), those are billed separately at our in-clinic rates.

Yes. We accept Quest, LabCorp, hospital-system labs, and direct-to-consumer providers like Marek Health if the panel includes the markers we need. Many patients use us for the prescription and monitoring while running labs through their primary care insurance to keep costs down. We'll send the order; you take it wherever you want.

Free testosterone is the bioavailable hormone—the part that's actually doing things in tissue. Total T is what most clinics report. Free T accounts for SHBG (sex hormone binding globulin), which can be elevated in older men or men with thyroid issues. We always interpret total alongside free and SHBG; one number alone doesn't tell the story.

Hematocrit (red blood cell concentration) is the most common TRT lab change to monitor. If it climbs above 53–54%, we adjust dose first. Therapeutic phlebotomy (blood donation) is the next lever—we coordinate with the regional blood center, and you've donated something useful in the process. Persistent high hematocrit despite dose adjustment is rare.

Testosterone aromatizes to estradiol, and estradiol matters for bone health, mood, libido, and cardiovascular function. Too low is as much a problem as too high. We use sensitive estradiol assays (not the standard immunoassay, which is unreliable for men) and only intervene when symptoms and lab values both point to a real issue.

Mild acne (especially first 6–8 weeks), oily skin, mood adjustment as your body recalibrates, occasional sleep changes, and elevated hematocrit on labs. Most resolve as the protocol stabilizes. Less common: tender or enlarged breast tissue (gynecomastia, usually responsive to dose adjustment), water retention, accelerated hair loss in genetically predisposed men.

Men with active prostate or breast cancer, severe untreated sleep apnea, polycythemia (high red blood cell count) at baseline, severe untreated heart failure, or men actively trying to conceive in the next 6 months are not candidates without modified protocols (or alternatives like enclomiphene). We screen for all of these at intake.

Decades of evidence suggest TRT does not cause prostate cancer in men with normal baseline PSA. It can accelerate growth of an existing undiagnosed cancer, which is why we check PSA at baseline (men 40+) and quarterly during the first year, then annually. The old "TRT causes prostate cancer" claim has been substantially walked back by major urology societies.

The 2023 TRAVERSE trial—the largest RCT to date—found no increase in major cardiovascular events from TRT in men with hypogonadism. Older observational studies suggesting risk had methodological problems. We still monitor blood pressure, lipids, and inflammatory markers during therapy. Men with recent cardiac events get a cardiology clearance before starting.

Mild-to-moderate: nausea, constipation, diarrhea, fatigue—usually titration-related. Concerning: severe persistent vomiting, severe abdominal pain (rule out gallbladder, pancreatitis), rapid heart rate, signs of dehydration, blood sugar that drops too low if you're also on diabetes meds. Call us for anything in the second category.

TRT has minimal interactions with most medications. GLP-1s slow gastric emptying and can affect absorption of oral medications taken simultaneously—we adjust timing for thyroid medication, oral antibiotics, oral contraceptives. Peptides have varying profiles. Bring a complete medication and supplement list to your first visit.

Call right away for: severe abdominal pain, persistent vomiting, chest pain, blood in stool/urine, signs of allergic reaction, rapidly worsening fatigue or swelling. Send a message and we'll respond same-day for: persistent injection-site reactions, mood changes, sleep disruption past week 4, side effects that are bothering you. Mention at next visit for: minor fluctuations, gradual concerns.

Dr. Farhan Abdullah, DO is a board-certified internal medicine physician and IFM-certified functional medicine practitioner. He serves as adjunct faculty at UT Southwestern, TCU, and UNTHSC, and works as a hospitalist physician in Dallas in addition to leading Magnolia Men's Health. Read his full bio.

Both. Many routine follow-ups are handled by our nurse practitioner, who is excellent and thoroughly trained in our protocols. Every treatment plan is built or personally reviewed by Dr. Abdullah, including those carried out by NP visits. New-patient intakes are typically with the physician.

Yes for follow-ups and most ongoing care after the first in-person visit. Texas regulations and good medicine both prefer an in-person intake. If you're far from Southlake, ask about our hybrid intake protocol—we can coordinate the lab and physical exam locally and run the consult by video.

2111 Kirkwood Blvd, Suite 110a, Southlake, TX 76092. We're between Kirkwood Boulevard and the 114, easy access from Trophy Club, Westlake, Colleyville, Keller, Grapevine, and Roanoke. Free parking right at the door.

Monday through Friday, 9 a.m. to 5 p.m. Early morning lab appointments (7:30 a.m.) are available by request—useful for accurate testosterone draws. We don't have weekend hours currently, but our patient portal is monitored 7 days a week and we respond to urgent issues same-day.

Patient portal messaging is the fastest route—we typically respond within a few hours during business days. Phone calls to (817) 749-6946 for anything urgent. After-hours, leave a voicemail and we return calls the next business morning; for true emergencies (chest pain, severe allergic reaction, severe abdominal pain), call 911.